SIC
HSTO

Salem Investment Counselors’s Histogen Inc. Common Stock HSTO Stock Holding History

Salem Investment Counselors’s Portfolio HSTO Stock Details HSTO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-1
Closed – – 1048
2021
Q2 		$0 Buy
+1
New +$21 ﹤0.01% 980

Other funds holding HSTO

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
MIH
Meitav Investment House Bene-Beraq, Israel $14.9B AUM 46.8% 1-Year Est. Return
VF
Virtu Financial New York $2.41B AUM 48.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
UCFA
United Capital Financial Advisors Irving, Texas $16.3B AUM 16.34% 1-Year Est. Return
N
Natixis Paris, France $28B AUM 26.79% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Salem Investment Counselors's HSTO Position: Q3 2021 in Review

Salem Investment Counselors sold out of Histogen Inc. Common Stock (HSTO) in Q3 2021, closing a stake of 1 share.

Salem Investment Counselors first reported a position in HSTO in Q2 2021 and held it in 1 quarter. The position peaked at $0 in Q2 2021. 22 funds tracked by Wall St. Rank hold HSTO as of Q3 2021.

  • Salem Investment Counselors reported no remaining Histogen Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • Salem Investment Counselors sold 1 Histogen Inc. Common Stock share in Q3 2021.
  • Salem Investment Counselors first reported a position in Histogen Inc. Common Stock in Q2 2021 and held it in 1 quarter.
  • Salem Investment Counselors's Histogen Inc. Common Stock position peaked at $0 in Q2 2021.
  • 22 funds tracked by Wall St. Rank held Histogen Inc. Common Stock as of Q3 2021.

Based on Salem Investment Counselors's 13F filing for Q3 2021, filed 15 Nov 2021.